Sanofi (SNYNF) Liabilities from Discontinued Operations (2009 - 2025)

Sanofi (SNYNF) posted Liabilities from Discontinued Operations of 2263919.38 for Q2 2025, down 99.9% sequentially from 2277176797.75 in Q4 2024.

Sanofi (SNYNF) Liabilities from Discontinued Operations (2009 - 2025) Analysis & Trends

Sanofi (SNYNF) has 17 years of Liabilities from Discontinued Operations data on file, last reported at 2263919.38 in Q2 2025.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 2263919.38 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was 2263919.38 (changed N/A YoY) and the FY2024 annual result came in at 2277176797.75, up 16093.45% from the prior year.
  • Liabilities from Discontinued Operations slipped to 2263919.38 in Q2 2025 per SNYNF's latest filing, from 2277176797.75 in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was 2277176797.75 in Q4 2024, with the low at 2263919.38 in Q2 2025.
  • Average Liabilities from Discontinued Operations over 5 years is 340533923.09, with a median of 18139963.7 recorded in 2022.
  • Year-over-year, Liabilities from Discontinued Operations dropped 16.32% in 2022 and jumped 16180.41% in 2024.
  • Sanofi's Liabilities from Discontinued Operations stood at 21676885.87 in 2021, then plunged by 52.93% to 10202473.65 in 2022, then jumped by 37.1% to 13987218.82 in 2023, then jumped by 16180.41% to 2277176797.75 in 2024, then plunged by 99.9% to 2263919.38 in 2025.
  • Business Quant data shows SNYNF's Liabilities from Discontinued Operations at 2263919.38 in Q2 2025, 2277176797.75 in Q4 2024, and 13987218.82 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Jun 30, 2025 2.26 Mn
Jun 30, 2025 2.26 Mn
Dec 31, 2024 2.28 Bn
Dec 31, 2024 2.28 Bn
Dec 31, 2023 13.99 Mn
Dec 31, 2023 13.99 Mn
Jun 30, 2023 40.29 Mn
Jun 30, 2023 40.29 Mn
Dec 31, 2022 10.20 Mn
Dec 31, 2022 10.20 Mn
Jun 30, 2022 18.14 Mn
Jun 30, 2022 18.14 Mn
Jun 30, 2021 21.68 Mn
Jun 30, 2021 21.68 Mn
Dec 31, 2020 38.15 Mn
Dec 31, 2020 38.15 Mn
Jun 30, 2020 7.71 Mn
Jun 30, 2020 7.71 Mn
Dec 31, 2019 6.64 Mn
Dec 31, 2019 6.64 Mn